We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
-17.83%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$404B
AUM Growth
-$174B
Cap. Flow
-$8.47B
Cap. Flow %
-2.09%
Top 10 Hldgs %
31.86%
Holding
14,668
New
1,801
Increased
4,898
Reduced
5,771
Closed
1,897

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$824M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$459M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$301M
4
WBD icon
Warner Bros
WBD
+$287M
5
TSLA icon
Tesla
TSLA
+$230M

Sector Composition

Rank Sector Weight
1 Miscellaneous 92.22%
2 Technology 1.79%
3 Consumer Discretionary 1.52%
4 Communication Services 1.04%
5 Financials 1.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HOOK
11976
PUT
DELISTED
HOOKIPA Pharma
HOOK
$43K ﹤0.01%
2,620
-3,380
-56% -$56K
LITB
11977
LightInTheBox
LITB
$63.9M
$43K ﹤0.01%
7,530
+3,593
+91% +$24.4K
RDHL
11978
Redhill Biopharma
RDHL
$3.83M
$43K ﹤0.01%
50
+11
+28% +$15.1K
SINT icon
11979
SiNtx Technologies
SINT
$10.2M
$43K ﹤0.01%
5
-2
-29% -$19.7K
TKC icon
11980
Turkcell
TKC
$4.7B
$43K ﹤0.01%
17,374
-1,643
-9% -$5.31K
TRUE
11981
PUT
DELISTED
TrueCar
TRUE
$43K ﹤0.01%
16,600
-12,000
-42% -$39.8K
AIFF
11982
Firefly Neuroscience
AIFF
$16.9M
$43K ﹤0.01%
+1,069
New +$103K
NEXI
11983
DELISTED
NexImmune, Inc. Common Stock
NEXI
$43K ﹤0.01%
+1,065
New +$65.9K
SQZ
11984
DELISTED
SQZ Biotechnologies Company
SQZ
$43K ﹤0.01%
13,549
+3,520
+35% +$12.7K
IVC
11985
PUT
DELISTED
Invacare Corporation
IVC
$43K ﹤0.01%
33,400
+4,400
+15% +$5.8K
STAB
11986
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
$43K ﹤0.01%
+151,848
New +$39.3K
MILE
11987
PUT
DELISTED
Metromile, Inc. Common Stock
MILE
$43K ﹤0.01%
46,900
-39,000
-45% -$39.8K
BCLI
11988
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$42K ﹤0.01%
1,022
-5,285
-84% -$238K
CCLD icon
11989
PUT
CareCloud
CCLD
$113M
$42K ﹤0.01%
12,100
-9,300
-43% -$36.9K
CUE icon
11990
CALL
Cue Biopharma
CUE
$205M
$42K ﹤0.01%
567
-3,430
-86% -$401K
GALT icon
11991
Galectin Therapeutics
GALT
$418M
$42K ﹤0.01%
32,327
-48,133
-60% -$69.2K
HIHO icon
11992
Highway Holdings
HIHO
$4.12M
$42K ﹤0.01%
18,368
-21,153
-54% -$48.8K
NVNO
11993
enVVeno Medical
NVNO
$7.81M
$42K ﹤0.01%
+319
New +$49.5K
PXS icon
11994
Pyxis Tankers
PXS
$55.3M
$42K ﹤0.01%
+15,391
New +$40.6K
CSCI
11995
PUT
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$42K ﹤0.01%
2,075
-152
-7% -$3.8K
SFE
11996
DELISTED
Safeguard Scientifics, Inc.
SFE
$42K ﹤0.01%
+11,165
New +$46.6K
TCRR
11997
PUT
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$42K ﹤0.01%
+14,400
New +$35.5K
AYTU icon
11998
CALL
AYTU BioPharma
AYTU
$24M
$41K ﹤0.01%
2,940
-195
-6% -$2.5K
FLUX icon
11999
Flux Power
FLUX
$13.6M
$41K ﹤0.01%
+17,055
New +$42.1K
IMMP
12000
PUT
Immutep
IMMP
$56.1M
$41K ﹤0.01%
20,300
+7,000
+53% +$17.3K

Similar funds

Jeff Yass's Q2 2022 Portfolio in Review

As of Q2 2022, Jeff Yass held 14,668 positions worth $404B, down 30% from $578B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Jeff Yass's Q2 2022 filing shows 1,801 new, 4,898 increased, 5,771 reduced and 1,897 closed positions. Its largest new stake was iShares US Treasury Bond ETF: 1,544,259 shares worth $36.9M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.88B.

By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, up from 92% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q2 2022 buy was iShares US Treasury Bond ETF: 1,544,259 shares worth $36.9M.
  • Jeff Yass added most to Amazon in Q2 2022, an estimated $824M increase.
  • Jeff Yass's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.88B.
  • Jeff Yass fully exited Discovery, Inc. Series C Common Stock in Q2 2022, selling an estimated $176M.
  • Jeff Yass's ten largest holdings make up 32% of its $404B portfolio in Q2 2022.
  • Jeff Yass opened 1,801 new positions and closed 1,897 in Q2 2022.
  • Jeff Yass's portfolio value fell 30% quarter-over-quarter to $404B.

Based on Susquehanna International Group's 13F filing for Q2 2022, filed 15 Aug 2022.